Gainers
- Pasithea Therapeutics KTTA stock increased by 33.33% to $1.96 during Thursday's regular session. As of 12:31 EST, Pasithea Therapeutics's stock is trading at a volume of 82.9 million, which is 3177.14% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $42.9 million.
- Qualigen Therapeutics QLGN stock rose 32.0% to $1.32. As of 12:31 EST, this security is trading at a volume of 31.2 million shares, making up 450.31% of its average full-day volume over the last 100 days. The company's market cap stands at $46.5 million.
- Allakos ALLK shares rose 27.01% to $10.86. The current volume of 78.7 million shares is 6186.1% of Allakos's average full-day volume over the last 100 days (last updated at 12:31 EST). The company's market cap stands at $589.8 million.
- Genocea Biosciences GNCA stock rose 19.04% to $1.24. Trading volume for this security as of 12:31 EST is 8.7 million, which is 4813.86% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $71.1 million.
- TRACON Pharmaceuticals TCON stock increased by 18.42% to $3.66. As of 12:31 EST, this security is trading at a volume of 843.9K shares, making up 420.5% of its average full-day volume over the last 100 days. The company's market cap stands at $71.1 million.
- Xilio Therapeutics XLO stock moved upwards by 16.7% to $16.14. The market value of their outstanding shares is at $443.3 million.
Losers
- Quidel QDEL shares decreased by 16.92% to $138.12 during Thursday's regular session. As of 12:31 EST, this security is trading at a volume of 3.2 million shares, making up 607.5% of its average full-day volume over the last 100 days. The company's market cap stands at $5.7 billion.
- Codex DNA DNAY shares decreased by 12.9% to $6.42. Codex DNA's stock is trading at a volume of 155.4K shares as of 12:31 EST. This is 194.66% of its average full-day volume over the last 100 days. The company's market cap stands at $188.1 million.
- Titan Pharmaceuticals TTNP shares declined by 10.8% to $1.11. Trading volume for this security as of 12:31 EST is 415.3K, which is 123.16% of its average full-day volume over the last 100 days. The company's market cap stands at $11.0 million.
- BiondVax Pharmaceuticals BVXV stock declined by 10.66% to $2.61. As of 12:31 EST, this security is trading at a volume of 3.3 million shares, making up 138.35% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $37.3 million.
- Evelo Biosciences EVLO stock decreased by 10.26% to $7.18. As of 12:31 EST, this security is trading at a volume of 216.3K shares, making up 63.18% of its average full-day volume over the last 100 days. The company's market cap stands at $383.8 million.
- Veracyte VCYT shares declined by 7.34% to $40.42. As of 12:31 EST, this security is trading at a volume of 207.7K shares, making up 39.35% of its average full-day volume over the last 100 days. The company's market cap stands at $2.8 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in